Bank of New York Mellon
NTRP

Bank of New York Mellon’s Neurotrope, Inc. Common NTRP Stock Holding History

Bank of New York Mellon’s Portfolio NTRP Stock Details NTRP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-13,156
Closed -$68K – 4420
2017
Q3 		$68K Buy
13,156
+1,300
+11% +$6.82K ﹤0.01% 4056
2017
Q2 		$111K Buy
+11,856
New +$127K ﹤0.01% 4006

Other funds holding NTRP

CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tanaka Capital Management New York $59.9M AUM
OCMI
Oaktop Capital Management II Chatham, New Jersey $2.35B AUM 214.39% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
JMPWA
JP Morgan Private Wealth Advisors San Francisco, California $35B AUM 24.26% 1-Year Est. Return
Eagle Capital Management (New York)
Eagle Capital Management (New York) New York $29.8B AUM 12.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
PFO
Pathstone Family Office Englewood, New Jersey $13.1B AUM 21.02% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Bank of New York Mellon's NTRP Position: Q4 2017 in Review

Bank of New York Mellon sold out of Neurotrope, Inc. Common (NTRP) in Q4 2017, closing a stake of 13,156 shares — an estimated $68K sold.

Bank of New York Mellon first reported a position in NTRP in Q2 2017 and held it in 2 quarters. The position peaked at $111K in Q2 2017. 22 funds tracked by Wall St. Rank hold NTRP as of Q4 2017.

  • Bank of New York Mellon reported no remaining Neurotrope, Inc. Common position as of Q4 2017 after selling out during the quarter.
  • Bank of New York Mellon sold 13,156 Neurotrope, Inc. Common shares in Q4 2017, an estimated $68K.
  • Bank of New York Mellon first reported a position in Neurotrope, Inc. Common in Q2 2017 and held it in 2 quarters.
  • Bank of New York Mellon's Neurotrope, Inc. Common position peaked at $111K in Q2 2017.
  • 22 funds tracked by Wall St. Rank held Neurotrope, Inc. Common as of Q4 2017.

Based on Bank of New York Mellon's 13F filing for Q4 2017, filed 9 Feb 2018.